A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

NCT05548556 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Facioscapulohumeral Muscular Dystrophy (FSHD)

Interventions

DRUG: Placebo
DRUG: RO7204239

Sponsor

Hoffmann-La Roche